Lauren Merendino Myovant Sciences Ltd. (MYOV) insider trading activity

Lauren Merendino is Chief Commercial Officer of Myovant Sciences Ltd.. Currently has a direct ownership of 0 shares of MYOV, which is worth approximately $0. The most recent transaction as insider was on Mar 10, 2023, when has been sold 169,538 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Lauren Merendino Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2023	SELL Sale (or disposition) back to the issuer	-	169,538 Reduced 100.0%	0 Common Shares
Jan 18 2023	SELL Open market or private sale	$53,995 $26.89 p/Share	2,008 Reduced 1.17%	169,538 Common Shares
Oct 18 2022	SELL Open market or private sale	$42,916 $25.2 p/Share	1,703 Reduced 0.98%	171,546 Common Shares
Jul 18 2022	SELL Open market or private sale	$21,930 $12.87 p/Share	1,704 Reduced 0.97%	173,249 Common Shares
Apr 19 2022	SELL Open market or private sale	$73,662 $10.45 p/Share	7,049 Reduced 3.87%	174,953 Common Shares
Apr 15 2022	BUY Grant, award, or other acquisition	-	103,703 Added 36.3%	182,002 Common Shares
Apr 15 2021	BUY Grant, award, or other acquisition	-	78,299 Added 50.0%	78,299 Common Shares

Also insider at

EPIX

ESSA Pharma Inc. Healthcare